Key weight loss results at 48 weeks by group: Response rates at 48 weeks (12 mg dose): 100% achieved greater than or equal to 5% weight loss 93% achieved greater than or equal to 10% weight loss 83% achieved greater than or equal to 15% weight loss The cardiometabolic improvements were also significant, with reductions in blood pressure, triglycerides, LDL cholesterol, HbA1c, fasting glucose, and fasting insulin across all dose groups
Tchang coauthored a review of dietary supplements and alternative therapies for weight loss, which found that none were proven to be safe and effective
For patients currently using retatrutide through research channels, transitioning from other GLP-1 medications requires careful dose mapping and expectation management regarding treatment duration
References: Ravella S
Nauck MA, Vilsbll T, Gallwitz B, Garber A, Madsbad S (2009) Incretin-based therapies
This guide will help you understand why fatigue can happen during weight loss, how sleep and recovery affect energy levels, and how to move in ways that support your body rather than push it past its limits